ExLibris header image
SFX Logo
Title: Activation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: a systems medicine approach
Source:

Cell death & Disease [2041-4889] Murphy, Á C yr:2013


Collapse list of basic services Basic
Full text
Full text available via Nature
GO
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Peterson, Q. "PAC-1 Activates Procaspase-3 in Vitro through Relief of Zinc-Mediated Inhibition." Journal of molecular biology 388.1 (2009): 144-158. Link to SFX for this item
2. Weller, M. "Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network." Journal of clinical oncology 27.34 (2009): 5743-50. Link to SFX for this item
3. Peterson, Q. "Procaspase-3 Activation as an Anti-Cancer Strategy: Structure-Activity Relationship of Procaspase-Activating Compound 1 (PAC-1) and Its Cellular Co-Localization with Caspase-3." Journal of medicinal chemistry 52.18 (2009): 5721-5731. Link to Full Text for this item Link to SFX for this item
4. West, Diana C. "Differential effects of procaspase-3 activating compounds in the induction of cancer cell death." Molecular pharmaceutics 9.5 (2012): 1425-34. Link to Full Text for this item Link to SFX for this item
5. Stupp, P. "MGMT gene silencing and benefit from temozolomide in glioblastoma." New England Journal of Medicine, The 352.10 (2005): 997-1003. Link to SFX for this item
6. Fulop, Z. "A permeation method for detection of self-aggregation of doxorubicin in aqueous environment." International journal of pharmaceutics 454.1 (2013): 559-561. Link to SFX for this item
7. Dunn, J. "Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy." The British Journal of Cancer 101.1 (2009): 124-131. Link to Full Text for this item Link to SFX for this item
8. Lamszus, K. "Inhibition of glioblastoma growth in a highly invasive nude mouse model can be achieved by targeting epidermal growth factor receptor but not vascular endothelial growth factor receptor-2." Clinical cancer research 14.17 (2008): 5447-58. Link to SFX for this item
9. Haapasalo, K. "Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival." Neuropathology and applied neurobiology 32.4: 441-50. Link to SFX for this item
10. Truong-Tran AQ, Ai Q. "Apoptosis in the normal and inflamed airway epithelium: role of zinc in epithelial protection and procaspase-3 regulation." Biochemical Pharmacology 66.8 (2003): 1459-1468. Link to SFX for this item
11. Yarden, Y. "Untangling the ErbB signalling network." Nature reviews. Molecular cell biology 2.2 (2001): 127-37. Link to Full Text for this item Link to SFX for this item
12. Stupp, R. "Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma." The New England journal of medicine 352.10 (2005): 987-96. Link to SFX for this item
13. Hwang, Paul J H. "Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy." Nature chemical biology 2.10 (2006): 543-50. Link to Full Text for this item Link to SFX for this item
14. Olayioye, N E A. "The ErbB signaling network: receptor heterodimerization in development and cancer." The EMBO journal 19.13 (2000): 3159-3167. Link to Full Text for this item Link to SFX for this item
15. Hynes, Nancy E E. "ERBB receptors and cancer: the complexity of targeted inhibitors." Nature reviews. Cancer 5.5 (2005): 341-54. Link to Full Text for this item Link to SFX for this item
16. Esteller, M. "Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents." The New England journal of medicine 343.19 (2000): 1350-4. Link to SFX for this item
17. Charkoudian, Katherine J K. "A pro-chelator triggered by hydrogen peroxide inhibits iron-promoted hydroxyl radical formation." Journal of the American Chemical Society 128.38 (2006): 12424-12425. Link to Full Text for this item Link to SFX for this item
18. Sivarajah, Stephen J H. "ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium." Journal of Molecular and Cellular Cardiology 44.5 (2008): 831-54. Link to SFX for this item
19. Westphal, M. "Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial." Acta neurochirurgica 148.3 (2006): 269-75. Link to Full Text for this item Link to SFX for this item
20. Hynes, Nancy E. "ErbB receptors and signaling pathways in cancer." Current opinion in cell biology 21.2 (2009): 177-184. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.